21 November 2023 | Tuesday | News
“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innovations, Exactech is focused on pushing technological boundaries to deliver a best-in-class platform of enabling technologies and smart solutions. With a commitment to research and transformative technologies, such as a first-to-market surgical guidance system, machine learning-based tools and personalized planning solutions, we are delivering on our vision to unlock data insights through cross-platform, economical innovations that improve clinical outcomes.”
Active Intelligence was launched in 2021 as a dynamic ecosystem of enabling technologies and smart solutions that provides unparalleled support to surgeons in and out of the operating room. With powerful planning software, prediction tools, disruptive surgical technologies and engagement opportunities, Exactech AI empowers surgeons with data-rich, low-cost solutions that help improve patient outcomes.
Some notable achievements of Exactech AI include:
For more information, visit www.ExactechAI.com.
ExactechGPS, Equinoxe Planning App and Predict+ are developed by Blue Ortho, an Exactech subsidiary, and distributed by Exactech, Inc.
© 2024 Biopharma Boardroom. All Rights Reserved.